Hypertension Trial, Recruiting NCT07031739 Sponsor: Wake Forest University Health Sciences Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07031739
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who speak English or Spanish
  • People who have been diagnosed with high blood pressure
  • People who have been prescribed at least one medication to lower blood pressure (such as a water pill, calcium channel blocker, beta-blocker, ACE inhibitor, or ARB)
  • People whose last two blood pressure readings at their regular doctor were 130/80 mmHg or higher
  • People who have visited their regular doctor in the past 6 months
  • People who have been identified as experiencing food insecurity based on a standard two-question screening tool called the Hunger Vital Sign

Who may not be able to join:

  • People whose blood pressure is very high (top number above 210 mmHg or bottom number above 120 mmHg)
  • People with significant memory or thinking difficulties, a major mental health condition that affects their ability to give consent, or a serious medical condition that limits life expectancy or requires active ongoing treatment (such as certain cancers)
  • People who are pregnant, breastfeeding, or planning to become pregnant in the next 6 months
  • People who are planning to move out of the local area within the next 6 months
  • People who do not have safe, stable housing
  • People who do not have the ability to store meals at home
  • People who do not have access to a telephone

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Deepak Palakshappa, MD, MSHP, Wake Forest University Health Sciences

Phone: 336-713-5544

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 August 2025
Est. completion
1 September 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Systolic blood pressure value; Diastolic blood pressure value; Dietary Approaches to Stop Hypertension (DASH) diet adherence Score; Medication adherence Score; Food Security Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov